Nucleotide substitution in the ectodomain of TRAIL receptor DR4 is associated with lung cancer and head and neck cancer

Michael J. Fisher, Arvind K. Virmani, Li Wu, Richard Aplenc, Jeffrey C. Harper, Steven M. Powell, Timothy R. Rebbeck, David Sidransky, Adi F. Gazdar, Wafik S. El-Deiry

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Nucleotide substitution in the ectodomain of TRAIL receptor DR4 is associated with lung cancer and head and neck cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences